BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15577943)

  • 1. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
    Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM
    EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffolding by ERK3 regulates MK5 in development.
    Schumacher S; Laass K; Kant S; Shi Y; Visel A; Gruber AD; Kotlyarov A; Gaestel M
    EMBO J; 2004 Dec; 23(24):4770-9. PubMed ID: 15538386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif.
    Aberg E; Torgersen KM; Johansen B; Keyse SM; Perander M; Seternes OM
    J Biol Chem; 2009 Jul; 284(29):19392-401. PubMed ID: 19473979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4.
    Aberg E; Perander M; Johansen B; Julien C; Meloche S; Keyse SM; Seternes OM
    J Biol Chem; 2006 Nov; 281(46):35499-510. PubMed ID: 16971392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology.
    Brand F; Schumacher S; Kant S; Menon MB; Simon R; Turgeon B; Britsch S; Meloche S; Gaestel M; Kotlyarov A
    Mol Cell Biol; 2012 Jul; 32(13):2467-78. PubMed ID: 22508986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK5: A novel regulator of cardiac fibroblast function?
    Sahadevan P; Allen BG
    IUBMB Life; 2017 Oct; 69(10):785-794. PubMed ID: 28941148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5.
    Déléris P; Rousseau J; Coulombe P; Rodier G; Tanguay PL; Meloche S
    J Cell Physiol; 2008 Dec; 217(3):778-88. PubMed ID: 18720373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5.
    Kant S; Schumacher S; Singh MK; Kispert A; Kotlyarov A; Gaestel M
    J Biol Chem; 2006 Nov; 281(46):35511-9. PubMed ID: 16973613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress.
    Seternes OM; Johansen B; Hegge B; Johannessen M; Keyse SM; Moens U
    Mol Cell Biol; 2002 Oct; 22(20):6931-45. PubMed ID: 12242275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.
    Déléris P; Trost M; Topisirovic I; Tanguay PL; Borden KL; Thibault P; Meloche S
    J Biol Chem; 2011 Feb; 286(8):6470-8. PubMed ID: 21177870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does MK5 reconcile classical and atypical MAP kinases?
    Perander M; Keyse SM; Seternes OM
    Front Biosci; 2008 May; 13():4617-24. PubMed ID: 18508533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.
    Ronkina N; Schuster-Gossler K; Hansmann F; Kunze-Schumacher H; Sandrock I; Yakovleva T; Lafera J; Baumgärtner W; Krueger A; Prinz I; Gossler A; Kotlyarov A; Gaestel M
    Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2.
    Perander M; Al-Mahdi R; Jensen TC; Nunn JA; Kildalsen H; Johansen B; Gabrielsen M; Keyse SM; Seternes OM
    Sci Rep; 2017 Mar; 7():43471. PubMed ID: 28252035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.
    Al-Mahdi R; Babteen N; Thillai K; Holt M; Johansen B; Wetting HL; Seternes OM; Wells CM
    Cell Adh Migr; 2015; 9(6):483-94. PubMed ID: 26588708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the activation, interaction partners and possible functions of MK5/PRAK.
    Perander M; Keyse SM; Seternes OM
    Front Biosci (Landmark Ed); 2016 Jan; 21(2):374-84. PubMed ID: 26709779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation.
    Soulez M; Tanguay PL; Dô F; Dort J; Crist C; Kotlyarov A; Gaestel M; Ferron M; Dumont NA; Meloche S
    J Cell Physiol; 2022 Apr; 237(4):2271-2287. PubMed ID: 35141958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine residue 115 of MAPK-activated protein kinase MK5 is crucial for its PKA-regulated nuclear export and biological function.
    Kostenko S; Shiryaev A; Gerits N; Dumitriu G; Klenow H; Johannessen M; Moens U
    Cell Mol Life Sci; 2011 Mar; 68(5):847-62. PubMed ID: 20734105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ser(186) phospho-acceptor site within ERK4 is essential for its ability to interact with and activate PRAK/MK5.
    Perander M; Aberg E; Johansen B; Dreyer B; Guldvik IJ; Outzen H; Keyse SM; Seternes OM
    Biochem J; 2008 May; 411(3):613-22. PubMed ID: 18248330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ERK3/MK5 complex for treatment of obesity and diabetes.
    Loza-Valdes A; El-Merahbi R; Kassouf T; Demczuk A; Reuter S; Viera JT; Karwen T; Noh M; Löffler MC; Romero-Becerra R; Torres JL; Marcos M; Sabio G; Wojda U; Sumara G
    Biochem Biophys Res Commun; 2022 Jul; 612():119-125. PubMed ID: 35523049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK.
    Ronkina N; Johansen C; Bohlmann L; Lafera J; Menon MB; Tiedje C; Laaß K; Turk BE; Iversen L; Kotlyarov A; Gaestel M
    PLoS One; 2015; 10(8):e0136138. PubMed ID: 26295581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.